Ann: Cynata Successfully Completes Capital Raising, page-46

Sure, once Phase 1 is over, CYP will if you like be free carried for min 10% all future product sales...and get more than Cap in Cash.
Just remember we have got here on a single $5m raise until now in 2 years.

MSB for example had a cap of $550m recently, but had burnt through $500m of shareholders funds to arrive there.

They have already paid for the main cost which is the cells and are already to go of course.

We now have circa A$12m

But we could be done by end June, so with any delays, + the 90 days. By end of 2017, should be the biggest year ever for company.

Bit of ST pain, but LT gain.

There is no need for any raise for 2017, and if Fuji come to party, then that's about end of capital required for current programs.

Cynata have enough now to develop in parallel as they mentioned today, respiratory, Asthma, to speed things up. and add value.

I just think the model here is misunderstand even by holders that may have not looked deeply into business model.